Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
IJMS | Free Full-Text | Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Hypoglycaemia following JAK inhibitor treatment in patients with diabetes | Annals of the Rheumatic Diseases
Current and future status of JAK inhibitors - The Lancet
Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors - Welsch - 2017 - European Journal of Immunology - Wiley Online Library
Understanding STAT3, the intersection of many carcinogenic signaling pathways
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
Ruxolitinib | CAS 941678-49-5 | InvivoGen
JCI - JAK inhibitors in autoinflammation
JAK-STAT Signaling Pathway - YouTube
The role of JAK/STAT signaling pathway and its inhibitors in diseases - ScienceDirect
The Potential of JAK/STAT Pathway Inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Pathways: JAK-STAT Signaling | www.antibodies-online.com
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia | Inflammation and Regeneration | Full Text
JAK/STAT signaling in hematological malignancies | Oncogene
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
Targeting the JAK/STAT pathway in solid tumors
The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment
JCI - The suppressor of cytokine signaling–1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury
Viruses | Free Full-Text | JAK-STAT Pathway: A Novel Target to Tackle Viral Infections
